Retatrutide is a multi-receptor peptide agonist targeting GLP-1, GIP, and glucagon receptors, designed for advanced metabolic research
Without the right nutrition and lifestyle support, people can experience unnecessary side effects, nutrient deficiencies, muscle loss and weight regain once the drug is stopped
Similar analyses show that with exenatide treatment, not only cases with acute pancreatitis (or all pancreatitis) were reported more frequently but also cases suggestive of chronic pancreatitis (details not shown)
Tirzepatide activates two receptors GLP-1 and GIP
PubMed , How Does Semaglutide Work? Mayo Clinic Diet , 23 May 2024, Kodoth, Varna, et al
Until the FDA reviews the full evidence and approves it, retatrutide wont be legally available as a prescription drug